Strong Quarter For Cephalon, But Questions Linger on Provigil/Nuvigil
This article was originally published in The Pink Sheet Daily
Executive Summary
Despite setbacks in its plans to expand indications for its next-generation wakefulness drug, Nuvigil, Cephalon executives are confident of the drug's future.